United States· US:71335-1229_7030109d-5ce0-43f1-a5ed-16a3562acd40
Ciprofloxacin
A ciprofloxacin product containing ciprofloxacin hydrochloride, registered in United States by Bryant Ranch Prepack. The same ATC class is registered in 17 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Ciprofloxacin is registered in 17 of 19 countries.
Countries holding a registration under ATC J01MA02 (ciprofloxacin), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 10 of them publish a price we can compare per daily dose
Ciprofloxacin · ATC J01MA02
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ciprofloxacin costs, country by country.
Normalised to the WHO defined daily dose (1 g), the median price runs from $2.33 in Italy to $6.51 in Switzerland — a ×2.8 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ciprofloxacin · price per daily dose (1 g)
USD · FX 28 Sept 2026
- CH Switzerland$6.51
- IT Italy$2.33
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- CIPROFLOXACIN HYDROCHLORIDE
- Manufacturer
- Bryant Ranch Prepack
- Country
- United States (US)
- ATC code
- J01MA02
- ATC class
- Ciprofloxacin
- Defined daily dose
- 1 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 20
- ndc1171335-1229-9
- ndc1171335-1229-0
- ndc1171335-1229-1
- ndc1171335-1229-2
- ndc1171335-1229-3
- ndc1171335-1229-4
- ndc1171335-1229-5
- ndc1171335-1229-6
- ndc1171335-1229-7
- ndc1171335-1229-8
- ndc1171335122907 TABLET, COATED in 1 BOTTLE (71335-1229-0)
- ndc11713351229114 TABLET, COATED in 1 BOTTLE (71335-1229-1)
- ndc11713351229230 TABLET, COATED in 1 BOTTLE (71335-1229-2)
- ndc11713351229320 TABLET, COATED in 1 BOTTLE (71335-1229-3)
- ndc11713351229460 TABLET, COATED in 1 BOTTLE (71335-1229-4)
- ndc1171335122956 TABLET, COATED in 1 BOTTLE (71335-1229-5)
- ndc11713351229610 TABLET, COATED in 1 BOTTLE (71335-1229-6)
- ndc11713351229728 TABLET, COATED in 1 BOTTLE (71335-1229-7)
- ndc117133512298100 TABLET, COATED in 1 BOTTLE (71335-1229-8)
- ndc11713351229940 TABLET, COATED in 1 BOTTLE (71335-1229-9)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
616 interactions on record for ciprofloxacin.
Graded by severity as the source publishes them — 110 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ciprofloxacin · interactions on record
616 records
- 110 severe
- 266 moderate
- 61 minor
- 139 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- NaloxegolA06AH03severe
40 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under J01MA02
Ciprofloxacin, as other registers publish it.
- CanadaACT CIPROFLOXACINTEVA CANADA LIMITED
- CanadaACT CIPROFLOXACINTEVA CANADA LIMITED
- CanadaACT CIPROFLOXACINTEVA CANADA LIMITED
- CanadaAURO-CIPROFLOXACINAURO PHARMA INC
- CanadaAURO-CIPROFLOXACINAURO PHARMA INC
- SwitzerlandBactiflox 500, FilmtablettenAcino Pharma AG
- SwitzerlandBactiflox 500, FilmtablettenAcino Pharma AG
- SwitzerlandBactiflox 500, FilmtablettenAcino Pharma AG
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ca05b865-d7ed-40db-8546-f8f8763c441e GET /v1/drugs/ca05b865-d7ed-40db-8546-f8f8763c441e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "500",
"substance": "CIPROFLOXACIN HYDROCHLORIDE",
"productndc": "71335-1229",
"dosage_form": "TABLET, COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA208921",
"marketing_category": "ANDA"
}See everything about ciprofloxacin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.